ClinicalTrials.gg
RecruitingNCT06769438RAUCAMIENSUpdated Nov 2, 2026

Effectiveness of the RAUC Pathway in Reducing Unscheduled Hospitalizations After Emergency Digestive Surgery

An interventional study of ERAS and DEEPSEN in Digestive Emergency, New Pathway and Connected Health, sponsored by Centre Hospitalier Universitaire, Amiens. Recruiting at 6 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Centre Hospitalier Universitaire, Amiens · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 5 months later.
Updated Nov 2, 2026Primary completion movedStudy completion moved+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
3,048
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The number of emergencies's visits (22 million visits in 2019 in France), the organization of emergencies and the sustainability of the current health system are threatened. In the CHUAP adult emergency department, 60,000 visits were recorded in 2022.

Unlike medical emergencies which have structured their care and research activities (heart, brain), and whose organization has demonstrated its general interest for society, digestive surgical emergencies, which involve complex patients (elderly people, comorbidities) , emergency situations and surgical procedures, have never been thought of globally in terms of personalized care and research pathways. Currently, patients treated in emergency are managed without a pre-established optimization program and without a dedicated pathway, where emergency constitutes a major risk factor for postoperative complications.

RAUCAMIENS evaluates a new care pathway implemented within the framework of the RHU RAUC : the implementation of the Enhanced rehabilitation after surgery (ERAS) and e-health devices for home monitoring, for patients treated in the emergency room for a digestive pathology. The purpose is to evaluate the effectiveness of the RAUC pathway in reducing the rate of unplanned hospitalization readmission after emergency digestive surgery 30 days postoperative.

02

Conditions studied

  • Digestive Emergency
  • New Pathway
  • Connected Health

Keywords

  • digestive emergency
  • new pathway
  • connected health
03

In context

Lead sponsor

Centre Hospitalier Universitaire, Amiens is the lead sponsor of 586 studies on the registry; 185 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Criterion linked to the protocol :

    -- Patient consulted in emergency for a digestive pathology requiring surgery

  • Search criteria:

    • Adult patient (≥ 18 years old),
    • Able to give consent,
    • Affiliation to a social security scheme

Exclusion criteria

Exclusion Criteria:

  • Criterion linked to the protocol:

    • Patient leaving hospitalization to a convalescent center
    • Patient requiring direct operating room (vital emergency or surgical revision)
    • Patient presenting to the emergency room for a postoperative complication
    • Patient directly admitted to intensive care
  • Search criteria:

    • Pregnant or breastfeeding woman
    • Patient under guardianship, curatorship or deprived of liberty
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
3,048 participants (estimated)

Study arms

  • Experimental
    Experimental group

    patients included in the CHUAP RAUC + course

    Other: ERAS · Other: DEEPSEN · Other: RDS · Other: Get ready · Other: Lumiradx · Other: Digital Surgery

  • Active comparator
    Control group 1

    patients from other hospital included over the same period as patients from CHUAP benefiting from standard care (RAUC -)

    Other: ERAS

  • Active comparator
    Control group 2

    patients verifying the inclusion/non-inclusion criteria and from the SNDS over the period from January 1, 2022 to December 31, 2025

    Other: ERAS

Interventions

  • OtherERAS

    ERAS

  • OtherDEEPSEN

    virtual reality headset to reduce anxiety

  • OtherRDS

    patch to continuously monitor patients' physiological parameters at home

  • OtherGet ready

    digital solution for managing patients at home

  • OtherLumiradx

    taking CRP at home

  • OtherDigital Surgery

    recording of the different operating times

06

What researchers measure

Primary outcomes

  1. Occurrence of an unscheduled hospitalization readmission

    Occurrence of an unscheduled hospitalization readmission following digestive surgery performed urgently within 30 days

    Time frame: 30 days

Secondary outcomes

  1. assess morbidity and mortality

    Clavien-Dindo score

    Time frame: 30 days

  2. evaluaate the effectiveness of the RAUC pathway on the lenght of hospital stay on first admission for emergency digestive surgery

    lenght of hospital stay for first admission for emergency digestive surgery

    Time frame: 30 days

  3. evaluate the quality of life of patients with or without a RAUC pathway

    Quality of life assessed by the scores of the different dimensions of the EQ-5D-5L which is a PROMS, at admission and the postoperative visit

    Time frame: 0 day

  4. Assessing patient anxietys

    Anxiety assessed by a VAS

    Time frame: 30 days

  5. assess wether the patient has returned to the emergency department without being hospitalized

    non-hospitalized emergency room visits

    Time frame: 0 day

  6. medico economic evaluation of the RAUC pathway

    incremental cost-utility ratio (cost/QALY) and ncremental cost-effectiveness ratio (cost per readmission avoided)

    Time frame: 30 days

07

Study locations

6 of 6 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Jun 2025 (actual). Primary completion is estimated for Jul 2027, 25 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 2, 2026: primary completion Nov 2026 → Jul 2027 and completion Aug 2027 → Feb 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 7, 2025
First posted
Jan 10, 2025
StartActual
Jun 2, 2025
Primary completionEst.
Jul 2027was Nov 2026
CompletionEst.
Feb 2028was Aug 2027
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Sites
5 sites added, 1 site removed
Show 5 added (5 France)
  • Centre Hospitalier de Beauvais · Beauvais, France
  • CHU Angers · Angers, France
  • Hopital Avicenne APHP · Bobigny, France
  • Hopital Cochin - Port Royal APHP · Paris, France
  • Centre Hospitalier Universitaire, Amiens · Salouël, France
Show 1 removed
  • Centre Hospitalier Universitaire, Amiens · Salouel, France
Nov 2, 2026
Primary completion
Nov 2026→Jul 2027
Nov 2, 2026
Study completion
Aug 2027→Feb 2028
Nov 2, 2026
Enrollment
3000→3048
Nov 2, 2026
Interventions
Removed ROFIM
Nov 2, 2026
Secondary outcomes
6 added, 8 removed
What changed in the outcomes
  • Addedassess morbidity and mortalityTime frame: 30 days
  • Addedevaluaate the effectiveness of the RAUC pathway on the lenght of hospital stay on first admission for emergency digestive surgeryTime frame: 30 days
  • Addedevaluate the quality of life of patients with or without a RAUC pathwayTime frame: 0 day
  • AddedAssessing patient anxietysTime frame: 30 days
  • Addedassess wether the patient has returned to the emergency department without being hospitalizedTime frame: 0 day
  • Addedmedico economic evaluation of the RAUC pathwayTime frame: 30 days
  • RemovedClavien-Dindo scoreTime frame: 30 days
  • RemovedDuration of hospitalization linked to the first admission to perform emergency digestive surgeryTime frame: 30 days
  • RemovedQuality of life scoreTime frame: 0 day
  • RemovedQuality of Life scoreTime frame: 30 days
  • RemovedSTAI-Y scaleTime frame: 0 day
  • RemovedTransition to emergency without hospitalizationTime frame: 30 days
  • Removedincremental cost-utility ratioTime frame: 30 days
  • Removedincremental cost-effectiveness ratioTime frame: 30 days
Nov 2, 2026
Sponsor
Collaborators added: Centre Hospitalier de Beauvais·University Hospital, Angers·Hôpital Cochin·Assistance Publique Hopitaux Paris AVICENNE
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    5 sites added, 1 site removed
    Show 5 added (5 France)
    • Centre Hospitalier de Beauvais · Beauvais, France
    • CHU Angers · Angers, France
    • Hopital Avicenne APHP · Bobigny, France
    • Hopital Cochin - Port Royal APHP · Paris, France
    • Centre Hospitalier Universitaire, Amiens · Salouël, France
    Show 1 removed
    • Centre Hospitalier Universitaire, Amiens · Salouel, France
    Primary completion Nov 2026→Jul 2027
    Study completion Aug 2027→Feb 2028
    Enrollment 3000→3048
    Secondary outcomes 6 added, 8 removed
    What changed in the outcomes
    • Addedassess morbidity and mortalityTime frame: 30 days
    • Addedevaluaate the effectiveness of the RAUC pathway on the lenght of hospital stay on first admission for emergency digestive surgeryTime frame: 30 days
    • Addedevaluate the quality of life of patients with or without a RAUC pathwayTime frame: 0 day
    • AddedAssessing patient anxietysTime frame: 30 days
    • Addedassess wether the patient has returned to the emergency department without being hospitalizedTime frame: 0 day
    • Addedmedico economic evaluation of the RAUC pathwayTime frame: 30 days
    • RemovedClavien-Dindo scoreTime frame: 30 days
    • RemovedDuration of hospitalization linked to the first admission to perform emergency digestive surgeryTime frame: 30 days
    • RemovedQuality of life scoreTime frame: 0 day
    • RemovedQuality of Life scoreTime frame: 30 days
    • RemovedSTAI-Y scaleTime frame: 0 day
    • RemovedTransition to emergency without hospitalizationTime frame: 30 days
    • Removedincremental cost-utility ratioTime frame: 30 days
    • Removedincremental cost-effectiveness ratioTime frame: 30 days
    Interventions Removed ROFIM
    Sponsor Collaborators added: Centre Hospitalier de Beauvais·University Hospital, Angers·Hôpital Cochin·Assistance Publique Hopitaux Paris AVICENNE
    + 3 other changes: index terms, verification date and criteria formatting

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06769438
Collaborators
University Hospital, Rouen, Centre Hospitalier de Beauvais, University Hospital, Angers, Hôpital Cochin, Assistance Publique Hopitaux Paris AVICENNE
Responsible party
Sponsor
First posted
Jan 10, 2025
Start date
Jun 2, 2025
Primary completion
Jul 2027 (estimated)
Completion
Feb 2028 (estimated)
Last update
Nov 2, 2026

Study contacts

Jean Marc Regimbeau, Pr
Contact
regimbeau.jean-marc@chu-amiens.fr
33 + 322 088 897
Jean Marc Regimbeau, Pr
principal investigator · CHRU Amiens

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion